Altered expression of hepatic CYP2E1 and CYP4A in obese, diabetic ob/ob mice, and fa/fa Zucker rats

被引:100
作者
Enriquez, A [1 ]
Leclercq, I [1 ]
Farrell, GC [1 ]
Robertson, G [1 ]
机构
[1] Univ Sydney, Westmead Hosp, Storr Liver Unit, Dept Med, Westmead, NSW, Australia
关键词
D O I
10.1006/bbrc.1999.0202
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Hepatic levels of the cytochrome P450 (CYP) proteins 2E1 and 4A are often increased in obesity, diabetes and fasting. In such states of nutritional imbalance, CYPs 2E1 and 4A may play a more significant role in fatty acid oxidation. In order to more fully characterize the regulation of CYP2E1 and CYP4A in obesity and obesity-related (type II) diabetes, we analyzed the hepatic expression of CYP2E1 and CYP4A in ob/ob mice which are leptin deficient, and fa/fa Zucker rats which have defective leptin receptor function. CYP2E1 protein and mRNA were either unchanged or reduced in both models. Conversely, expression of murine CYP2E1 and 4a14 in the obese mice, and 4A2 in the male fatty Zucker rat, were greatly increased. The levels of other CYP4As were either unchanged or reduced. These results show that CYP2E1 is not inevitably increased by obesity and diabetes and indicate differential regulation of CYP4A subfamily genes in rodent models. Further, they implicate leptin receptor signaling as a factor that may modulate expression of CYP gene products involved in fatty acid oxidation. (C) 1999 Academic Press.
引用
收藏
页码:300 / 306
页数:7
相关论文
共 50 条
  • [1] Adas F, 1998, J LIPID RES, V39, P1210
  • [2] IDENTIFICATION AND CHARACTERIZATION OF DNA ELEMENTS IMPLICATED IN THE REGULATION OF CYP4A1 TRANSCRIPTION
    ALDRIDGE, TC
    TUGWOOD, JD
    GREEN, S
    [J]. BIOCHEMICAL JOURNAL, 1995, 306 : 473 - 479
  • [3] EVIDENCE THAT CYTOCHROME-P450 2E1 IS INVOLVED IN THE (OMEGA-1)-HYDROXYLATION OF LAURIC ACID IN RAT-LIVER MICROSOMES
    AMET, Y
    BERTHOU, F
    GOASDUFF, T
    SALAUN, JP
    LEBRETON, L
    MENEZ, JF
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1994, 203 (02) : 1168 - 1174
  • [4] Validation of the (omega-1)-hydroxylation of lauric acid as an in vitro substrate probe for human liver CYP2E1
    Amet, Y
    Berthou, F
    Baird, S
    Dreano, Y
    Bail, JP
    Menez, JF
    [J]. BIOCHEMICAL PHARMACOLOGY, 1995, 50 (11) : 1775 - 1782
  • [5] SEX-DIFFERENCES IN THE DIABETES-INDUCED MODULATION OF RAT HEPATIC CYTOCHROME-P450 PROTEINS
    BARNETT, CR
    RUDD, S
    FLATT, PR
    IOANNIDES, C
    [J]. BIOCHEMICAL PHARMACOLOGY, 1993, 45 (02) : 313 - 319
  • [6] SPECIES-SPECIFIC INDUCTION OF CYTOCHROME-P-450 4A-RNAS - PCR CLONING OF PARTIAL GUINEA-PIG, HUMAN AND MOUSE CYP4A-CDNAS
    BELL, DR
    PLANT, NJ
    RIDER, CG
    NA, L
    BROWN, S
    ATEITALLA, I
    ACHARYA, SK
    DAVIES, MH
    ELIAS, E
    JENKINS, NA
    GILBERT, DJ
    COPELAND, NG
    ELCOMBE, CR
    [J]. BIOCHEMICAL JOURNAL, 1993, 294 : 173 - 180
  • [7] BELLWARD GD, 1988, MOL PHARMACOL, V33, P140
  • [8] CHAN YL, 1984, J BIOL CHEM, V259, P224
  • [9] Phenotypes of mouse diabetes and rat fatty due to mutations in the OB (leptin) receptor
    Chua, SC
    Chung, WK
    WuPeng, XS
    Zhang, YY
    Liu, SM
    Tartaglia, L
    Leibel, RL
    [J]. SCIENCE, 1996, 271 (5251) : 994 - 996
  • [10] Phenotype of fatty due to Gln269Pro mutation in the leptin receptor (Lepr)
    Chua, SC
    White, DW
    WuPeng, XS
    Liu, SM
    Okada, N
    Kershaw, EE
    Chung, WK
    PowerKehoe, L
    Chua, M
    Tartaglia, LA
    Leibel, RL
    [J]. DIABETES, 1996, 45 (08) : 1141 - 1143